Biotech

Fox Resources Signed Share Purchase Agreement to Purchase Oil and Gas Interests in Montana

VANCOUVER, BRITISH COLUMBIA: ...

Cleveland BioLabs Announces Opening of New IND for CBLB502 in Cancer Patients

BUFFALO, NY: Roswell Park Cancer Institute Approves First Trial Protocol ...

Marina Biotech Demonstrates In Vivo Dose-Dependent Efficacy and High Tolerability With a CRN-Substituted miRNA Antagonist

BOTHELL, WA: A microRNA (miRNA) Antagonist Substituted With Marina Biotech's Proprietary Conformationally Restricted Nucleotides (CRN) Produced Dose-Dependent, In Vivo De-Repression of Multiple Downstream Tar ...

RXT 110 Inc. Commences Litigation and Obtains Interim Injunctive Relief

TORONTO, ONTARIO: ...

ALLOZYNE Announces Positive Results From Phase 1B Trial of AZ01

SEATTLE, WA: ...

Standard & Poor's Initiates Stock Report Coverage on RepliCel Life Sciences Inc.

VANCOUVER, BRITISH COLUMBIA: ...

TOPICA Announces Completion of $27 Million Series B Financing

PALO ALTO, CA: Funding to Support Phase 2b/3 Clinical Development Program of Luliconazole for the Treatment of Onychomycosis ...

Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer

OREM, UT: ...

Marina Biotech, Inc. Announces a $15 Million Purchase Agreement With Lincoln Park Capital Fund, LLC

BOTHELL, WA: ...

Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested

BEVERLY, MA: Cellceutix Updates Shareholders; Answers Questions About Clinical Trials for Novel Cancer Drug ...